Watch CLB. Know when insiders buy.
One email the day a filing lands. Free.
CLB
Core Laboratories Inc. /DE/
12.62
+0.15 +1.20%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
46
WATCH · shorts 46
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $579.1MP/E 24.3DIV YIELD 0.32%FCF YIELD 2.61%REV TTM $519.2M +0.3%NET INCOME $24.4M −17.8%NET DEBT $93.6M52W 9.87 – 19.67SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $124.6M | −4.3% | 18.6% | $9.2M | $6M | −44.0% | 0.13 | $7.8M | $4.7M | $3.1M | Jul 30 |
| Q1 2026 · Mar 31 | $121.8M | −1.4% | 16.2% | $1.9M | −$789K | — | -0.02 | $4M | $3.4M | $517K | May 1 |
| Q4 2025 · Dec 31 | $138.3M | +7.0% | 20.8% | $15.8M | $4.9M | −33.2% | 0.11 | $7.9M | $2.9M | $5M | Mar 23 |
| Q3 2025 · Sep 30 | $134.5M | +0.1% | 22.0% | $20.9M | $14.2M | +21.2% | 0.30 | $8.5M | $2M | $6.5M | Oct 23 |
| Q2 2025 · Jun 30 | $130.2M | −0.3% | 20.3% | $15.3M | $10.6M | +17.8% | 0.22 | $13.9M | $3.5M | $10.4M | Jul 30 |
| Q1 2025 · Mar 31 | $123.6M | −4.7% | 19.5% | $4.4M | −$154K | −104.8% | 0.00 | $6.7M | $2.8M | $3.9M | May 1 |
| Q4 2024 · Dec 31 | $129.2M | +0.8% | 17.8% | $14.2M | $7.4M | +236.7% | 0.16 | $20.6M | $3.2M | $17.4M | Mar 23 |
| Q3 2024 · Sep 30 | $134.4M | +7.2% | 20.5% | $19.8M | $11.7M | +26.9% | 0.25 | $13.1M | $2.7M | $10.4M | Oct 23 |
| Q2 2024 · Jun 30 | $130.6M | — | 21.2% | $16M | $9M | — | 0.19 | $17.1M | $2.9M | $14.3M | Jul 25 |
| Q1 2024 · Mar 31 | $129.6M | — | 19.3% | $8.6M | $3.2M | — | 0.07 | $5.5M | $3.1M | $2.5M | Apr 28 |
| Q4 2023 · Dec 31 | $128.2M | — | — | $14.6M | $2.2M | — | 0.04 | $19.4M | $2.7M | $16.7M | Mar 23 |
| Q3 2023 · Sep 30 | $125.3M | — | — | $14.7M | $9.3M | — | 0.19 | −$212K | $3.5M | −$3.7M | Oct 24 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $526.5M | 20.7% | $56.5M | $29.7M | 5.6% | 0.63 | $37M | $11.2M | $25.8M | $12.4M | $1.9M |
| FY2024 · to Dec 31 | $523.8M | 19.7% | $58.6M | $31.4M | 6.0% | 0.66 | $56.4M | $11.9M | $44.5M | $5.3M | $1.9M |
| FY2023 · to Dec 31 | $509.8M | 21.5% | $54.6M | $36.7M | 7.2% | 0.77 | $24.8M | $10.6M | $14.2M | $2.2M | $1.9M |
| FY2022 · to Dec 31 | $489.7M | 19.6% | $41.5M | $19.5M | 4.0% | 0.42 | $25M | $10.2M | $14.7M | $3.9M | $1.9M |
| FY2021 · to Dec 31 | $470.3M | — | $45.3M | $19.7M | 4.2% | 0.42 | $36.6M | $13.5M | $23M | $8.3M | $1.8M |
Every number comes from Core Laboratories Inc. /DE/'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.